|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.200 USD | -2.26% |
|
-0.57% | +72.76% |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 726M 631M 588M 540M 1.02B 69.33B 1.03B 6.93B 2.72B 34.51B 2.73B 2.67B 116B | P/E 2026 * |
-8.01x | P/E 2027 * | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 591M 513M 478M 439M 829M 56.38B 841M 5.63B 2.21B 28.07B 2.22B 2.17B 94.12B | EV / Sales 2026 * |
103x | EV / Sales 2027 * | 112x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aclaris Therapeutics, Inc.
| 1 day | -2.26% | ||
| 1 week | -0.57% | ||
| 1 month | -1.70% | ||
| 3 months | +19.82% | ||
| 6 months | +48.15% | ||
| Current year | +72.76% |
| 1 week | 5.01 |  | 5.62 |
| 1 month | 5.01 | | 5.88 |
| Current year | 2.49 | | 5.88 |
| 1 year | 1.5 | | 5.88 |
| 3 years | 0.59 | | 10.15 |
| 5 years | 0.59 | | 19.97 |
| 10 years | 0.59 | | 33.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 2024-01-16 |
Hugh Davis
PSD | President | 67 | 2024-11-17 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 2022-12-31 |
Anand Mehra
BRD | Director/Board Member | 50 | 2014-08-31 |
| Director/Board Member | 59 | 2016-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/1/26 | Fiscal year | Chief Financial Officer | 5,427 | 0.0050% | ||
| 2/3/26 | Fiscal year | Executive/Senior Manager | 47,687 | 0.0440% | ||
| 2/3/26 | Fiscal year | Chief Financial Officer | 50,499 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.26% | -0.57% | +239.87% | -47.32% | 726M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -0.34% | -3.47% | +55.02% | +136.88% | 23.46B | |
| Weighted average by Cap. | +0.22% | -2.95% | +29.33% | +119.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.71M 4.97M 4.62M 4.24M 8.01M 545M 8.14M 54.48M 21.38M 271M 21.45M 20.98M 910M | 5.36M 4.66M 4.34M 3.98M 7.52M 512M 7.63M 51.11M 20.06M 255M 20.12M 19.68M 854M |
| Net income | -84.78M -73.7M -68.6M -62.98M -119M -8.09B -121M -809M -317M -4.03B -318M -311M -13.51B | -103M -89.12M -82.95M -76.16M -144M -9.79B -146M -978M -384M -4.87B -385M -377M -16.34B |
| Net Debt | -136M -118M -110M -101M -190M -12.94B -193M -1.29B -508M -6.44B -509M -498M -21.61B | -125M -109M -101M -92.79M -175M -11.92B -178M -1.19B -468M -5.94B -469M -459M -19.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$5.200 | -2.26% | 1,638,335 |
| 26-07-30 | US$5.320 | +3.91% | 1,905,224 |
| 26-07-29 | US$5.120 | -3.94% | 1,177,994 |
| 26-07-28 | US$5.330 | -0.74% | 1,552,980 |
| 26-07-27 | US$5.370 | +2.68% | 4,860,252 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACRS Stock
Select your edition
All financial news and data tailored to specific country editions
